<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>research | Handel Research Group</title>
    <link>https://handelgroup.uga.edu/tag/research/</link>
      <atom:link href="https://handelgroup.uga.edu/tag/research/index.xml" rel="self" type="application/rss+xml" />
    <description>research</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>Â©  Andreas Handel 2023 - information on this site does not reflect opinions of the University of Georgia</copyright><lastBuildDate>Sat, 17 Apr 2021 00:00:00 -0400</lastBuildDate>
    <image>
      <url>https://handelgroup.uga.edu/media/logo_hu5b753f44bbcc83398b978a15c08b2b08_90381_300x300_fit_lanczos_3.png</url>
      <title>research</title>
      <link>https://handelgroup.uga.edu/tag/research/</link>
    </image>
    
    <item>
      <title>SARS-CoV-2 vaccination modeling</title>
      <link>https://handelgroup.uga.edu/allprojects/covidvaccines/</link>
      <pubDate>Sat, 17 Apr 2021 00:00:00 -0400</pubDate>
      <guid>https://handelgroup.uga.edu/allprojects/covidvaccines/</guid>
      <description>&lt;p&gt;Building on our &lt;a href=&#34;https://handelgroup.uga.edu/allprojects/norovirusvaccines/&#34;&gt;norovirus vaccine work&lt;/a&gt;, we are working with the same group of collaborators to better understand the impact of different SARS-CoV-2 vaccination strategies.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Designing better influenza vaccines</title>
      <link>https://handelgroup.uga.edu/allprojects/influenzavaccines/</link>
      <pubDate>Sun, 07 Feb 2021 00:00:00 -0500</pubDate>
      <guid>https://handelgroup.uga.edu/allprojects/influenzavaccines/</guid>
      <description>&lt;p&gt;We are using modeling and analysis approaches to determine how to optimize vaccine formulation, with a focus on the impact of dose for future universal influenza vaccines. The work is part of the &lt;a href=&#34;https://www.niaidcivics.org/center-for-influenza-vaccine-research-for-high-risk-populations-civr-hrp/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP)&lt;/a&gt;, which is a component of NIH&amp;rsquo;s &lt;a href=&#34;https://www.niaidcivics.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Collaborative Influenza Vaccine Innovation Centers (CIVICs) program&lt;/a&gt;.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Model-guided vaccines for norovirus</title>
      <link>https://handelgroup.uga.edu/allprojects/norovirusvaccines/</link>
      <pubDate>Sun, 07 Feb 2021 00:00:00 -0500</pubDate>
      <guid>https://handelgroup.uga.edu/allprojects/norovirusvaccines/</guid>
      <description>&lt;p&gt;We are working on better understanding aspects of norovirus within-host and epidemiological dynamics and potential control. We analyze and model data that can inform the development and deployment of future norovirus vaccines. This is part of an NIH funded project with collaborators &lt;a href=&#34;https://www.blopman.net/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Ben Lopman&lt;/a&gt;, &lt;a href=&#34;https://scholarblogs.emory.edu/koellelab/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Katia Koelle&lt;/a&gt; and &lt;a href=&#34;https://www.sph.emory.edu/research/centers/leonlab/index.html&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Juan Leon&lt;/a&gt; at Emory, as well as colleagues from other universities, the CDC and Takeda.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Modeling and analysis of influenza immune responses</title>
      <link>https://handelgroup.uga.edu/allprojects/influenzaimmunity/</link>
      <pubDate>Sun, 17 Feb 2019 00:00:00 -0500</pubDate>
      <guid>https://handelgroup.uga.edu/allprojects/influenzaimmunity/</guid>
      <description>&lt;p&gt;We want to understand what mechanisms lead to good induction of memory immune responses following vaccination, and what mechanisms influence the severity of infections. To that end, we combine statistical and mechanistic models with data. We work on several projects in this area, some are part of the the &lt;a href=&#34;https://www.niaidcivics.org/center-for-influenza-vaccine-research-for-high-risk-populations-civr-hrp/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP)&lt;/a&gt;, others are part of the Center for Influenza Disease and Emergence Research (CIDER), a component of NIH&amp;rsquo;s &lt;a href=&#34;https://www.ceirr-network.org/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Centers of Excellence for Influenza Research and Response (CEIRR)&lt;/a&gt;, and some are part of the project &lt;a href=&#34;https://reporter.nih.gov/project-details/10204919&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Dynamics and Evolution of Immune Responses to Influenza Viruses&lt;/a&gt; with colleague &lt;a href=&#34;http://www.biology.emory.edu/Antia/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Rustom Antia as PI&lt;/a&gt; and other collaborators.&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
